뒤로
Minerva Surgical Inc (UTRS) 수입
UTRS 주가 차트
UTRS 수입
Minerva Surgical Inc
$0
0%
$0
종가: Mar 27, 16:00:00 GMT-4
$0
0%
$0
애프터마켓: Mar 27, 20:00:00 GMT-4
최신 수익 결과: Q3 '23
보고됨: 2023-11-13
역사적 수익
분기별
연간
EPS
수익
Earnings FAQ
UTRS의 최근 주당순이익(EPS)은 예상과 비교하여 어떤가요?
Minerva Surgical Inc UTRS의 지난 분기 매출 실적은 어땠나요?
Minerva Surgical Inc의 매출 추정치는 얼마인가요?
Minerva Surgical Inc의 수익 품질 점수는 얼마인가요?
Minerva Surgical Inc는 언제 수익을 보고하나요?
Minerva Surgical Inc의 예상 수익은 얼마인가요?
Minerva Surgical Inc은 수익 기대치를 충족했나요?
주요 통계
이전 종가
$0.0001
시가
$0.0001
일일 범위
$0.0001 - $0.0001
52주 범위
$0 - $0.001
거래량
500
평균 거래량
229
배당수익률
--
EPS(TTM)
-8.36
시가총액
$888
UTRS란 무엇인가요?
Minerva Surgical, Inc. is a medical technology company. The company is headquartered in Santa Clara, California and currently employs 174 full-time employees. The company went IPO on 2021-10-22. The firm designs, manufactures, distributes, and commercializes a suite of products that offer effective alternatives to hysterectomy, with a focus on diagnosing and treating the underlying causes of Abnormal Uterine Bleeding (AUB). Its solutions are designed for use across a variety of care settings and focused on improving clinical outcomes and preserve uterine anatomy. The company delivers devices that treat the root causes of AUB in both the normal and irregular shaped uterus. The firm's products include Minerva ES Endometrial Ablation System (Minerva ES), Genesys HTA Endometrial Ablation System (Genesys HTA), Symphion Operative Hysteroscopy System (Symphion), Resectr Tissue Resection Device (Resectr), and HERizon Disposable Hysteroscope. Its Minerva EAS includes PlasmaSense Technology, which monitors uterine cavity. The company also provides HERizon Hysto-Kit, which supports in-office hysteroscopy.